| |
|
2026 |
|
2025 |
| |
|
£ |
£ |
|
£ |
£ |
| Fixed assets |
|
|
15,074 |
|
|
- |
| Current assets |
|
90,400 |
|
|
9,845 |
|
| Creditors: amount falling due within one year |
|
(32,295) |
|
|
(6,099) |
|
|
Net current assets
|
|
|
58,105
|
|
|
3,746
|
|
Total assets less current liabilities
|
|
|
73,179 |
|
|
3,746 |
|
Net assets
|
|
|
73,179 |
|
|
3,746 |
| |
|
|
|
|
|
|
|
Capital and reserves
|
|
|
73,179 |
|
|
3,746 |
| |
NOTES TO THE ACCOUNTS
General Information
Forefront Bloodstock Ltd is a private company, limited by shares, registered in England and Wales, registration number 14679844, registration address 3 Brickfields Business Park, Old Stowmarket Road, Woolpit, Bury St Edmunds, 14679844, IP30 9QS.
The presentation currency is £ sterling.
| 1. |
Accounting policies
Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 105 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention.
The financial statements are prepared in sterling which is the functional currency of the company.
Turnover
Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.
Tangible fixed assets
Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
| Plant and Machinery |
20% Reducing Balance
|
|
| 2. |
Tangible fixed assets
| Cost or valuation |
Plant and Machinery |
|
Total |
| |
£ |
|
£ |
| At 01 March 2025 |
- |
|
- |
| Additions |
18,842 |
|
18,842 |
| Disposals |
- |
|
- |
| At 28 February 2026 |
18,842 |
|
18,842 |
| Depreciation |
| At 01 March 2025 |
- |
|
- |
| Charge for year |
3,768 |
|
3,768 |
| On disposals |
- |
|
- |
| At 28 February 2026 |
3,768 |
|
3,768 |
| Net book values |
| Closing balance as at 28 February 2026 |
15,074 |
|
15,074 |
| Opening balance as at 01 March 2025 |
- |
|
- |
|
| 3. |
Average number of employees
Average number of employees during the year was 2 (2025 : 2).
|
| 4. |
Related parties
During the year the company entered into the following transactions with related parties: | Amount due from/to related party | | Provision for doubtful debt from the related party |
|---|
| 2026
£ | | 2025
£ | | 2026
£ | | 2025
£ |
|---|
| Directors of Forefront Bloodstock Ltd | (15,194) | | (467) | | - | | - |
An interest free loan existed during the year. |
For the year ended 28 February 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' Responsibilities:
The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and FRS 105, the Financial Reporting Standard applicable to the micro-entities regime. The accounts have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The income statement has not been delivered to the Registrar of Companies.
The financial statements were approved by the board of directors on 14 April 2026 and were signed on its behalf by: --------------------------------
Lacey Dowse
Director |
2
|
